KeyCorp has been in the limelight due to a variety of factors. The company received
upgrade ratings from key analysts including UBS and KBW with
price targets ranging from $18.50 to $20. UBS has also proclaimed KeyCorp as a preferred buy. The company’s strength has been evidenced by its stock outperforming the S&P500, citing strong earnings and revenue performance that surpassed estimates.
Jim Cramer, a highly revered market analyst, advocated for the buy of KeyCorp stocks, admiring the company's longevity and consistent financial yields. This admiration is also echoed in regards to KeyCorp’s dividends, considered as safe yields sitting above 5% and among the best in the regional bank sector. Earnings growth is anticipated in Wall Street projections for KeyCorp’s upcoming
quarterly report.
KeyCorp’s stock has also exhibited a robust winning streak in the market. Promisingly, KeyCorp's
acquisition by Scotiabank has gained regulatory approval indicating further growth opportunities. Lastly, noteworthy appointments and strategic moves have taken place including the
appointment of Mohit Ramani as Chief Risk Officer and the announcement of a
share repurchase program.
Keycorp KEY News Analytics from Mon, 09 Sep 2024 07:00:00 GMT to Fri, 11 Jul 2025 07:00:00 GMT -
Rating 8
- Innovation -2
- Rumor 3
